Effects of first-line biologic immunomodulation compared with non-biologic therapies in adult-onset Still’s disease: a two-center cohort study
Abstract Background To evaluate comparative effectiveness of methotrexate (MTX), calcineurin inhibitors (CNI), Janus kinase inhibitors (JAKi), and biologics for the first-line therapies in adult-onset Still’s disease (AOSD) in real-world settings. Methods Two AOSD cohorts were r…